VolitionRx Ltd
VNRX
24 hedge funds and large institutions have $2.61M invested in VolitionRx Ltd in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 12 closing their positions.
2,489% more capital inflows, than outflows
Capital inflows: $2.02M | Capital outflows: $77.9K
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
16.51% less ownership
Funds ownership: 16.51% → 0% (-17%)
23% less funds holding
Funds holding: 31 → 24 (-7)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lagoda Investment Management
New York
|
+$1.56M |
| 2 |
Luminus Management
Houston,
Texas
|
+$258K |
| 3 |
Wealthspire Advisors (New York)
New York
|
+$82K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
+$55.7K |
| 5 |
Squarepoint
New York
|
+$25.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.4K |
| 3 |
Bank of New York Mellon
New York
|
-$11.2K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$8.19K |
| 5 |
Miller Financial Services
Marshall,
Michigan
|
-$6.26K |
VNRX Hedge Fund Activity: Q2 2026 in Review
24 of the 8,367 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2026, worth a combined $2.61M — down 42% from $4.52M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of VNRX and 5 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 7 added.
The largest buyer was Lagoda Investment Management, adding an estimated $1.56M. The largest seller was Geode Capital Management, cutting an estimated $14.4K.
- 24 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2026, down from 31 in Q1 2026.
- Funds reported $2.61M of VolitionRx Ltd stock for Q2 2026, down 42% quarter-over-quarter.
- 5 funds opened new VolitionRx Ltd positions in Q2 2026 and 12 closed out, a net change of -7 holders.
- The largest VolitionRx Ltd buyer in Q2 2026 was Lagoda Investment Management, an estimated $1.56M added.
- The largest VolitionRx Ltd seller in Q2 2026 was Geode Capital Management, an estimated $14.4K sold.
Based on aggregated 13F filings for Q2 2026.